The European Medicines Agency (EMA’s) safety committee (PRAC) has confirmed its recommendation to withdraw the marketing authorisations for amfepramone obesity medicines. The recommendation follows a review which found that measures to restrict the use of these...
The European Medicines Agency has published for public consultation a concept paper on platform trials. Platform trials have become more common in recent years. Currently, they are frequently seen in Scientific Advice and more rarely as part of Marketing...
EPTRI was present at the 20th International Conference on Pharmaceutical Medicine that was held last October 19 – 21, 2022 in Athens, Greece. This hybrid event was organised by the Greek Society of Pharmaceutical Medicine (ELEFI) and the International Federation of...
The International Conference on Research Infrastructures (ICRI) was held on 19 – 21 October, 2022 in the Czech Republic. During the three days event, four hundred and fifty participants, and almost a hundred of speakers talked about the sharing of research...
EPTRI was present at the Horizon4Poland’22 Conference held last November 22. Bonka Georgieva from our Coordination Team has participated at the break out session “How to boost Innovation with EU funds through public private partnership”, alongside with Nathalie...
The 2nd International Meet on Public Health and Healthcare Management will be held on December 5 – 7, 2022 in London, UK. At this congress the most recent public health and healthcare management development will be discussed by scientific experts in the field. The...
Biosimilars approved in the EU are interchangeable. The EU experts on biosimilar medicines (Biosimilar Medicines Working Party or BMWP) and the Heads of Medicines’ Agencies (HMA) Biosimilar Working Group have drafted a joint statement explaining the rationale for...
This conference entitled “Launch of Charter for EU Cooperation to Enable Safe and Timely Patient Access to Advanced Therapies in Europe” has been organized by the TRANSFORM MEP Interest Group of the European Alliance for Transformative Therapies. The in-person event...
The 20th International Conference on Pharmaceutical Medicine – ICPM, an event on biomedical science, pharmaceutical research and technology under the theme “What lies ahead in Pharmaceutical Medicine” will be held next week, on October 19th until the 21st, in Athens...
Cystic fibrosis (CF) is a life-shortening, monogenic, autosomal-recessive disorder, and has an estimated incidence of 1:2500 to 1:3500 live births. Newborn screening (NBS) has been implemented for CF in many European countries, Australia, New Zealand, Canada, and...